ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
SoftBank returns to back synthetic biology firm Zymergen in a $400M series C round
December 26, 2018Zymergen has raised over $400 million in a series C funding round, which it says will help double the capacity of its synthetic biology contract manufacturing platform..... -
SoftBank invests $1.1 billion in Roivant Sciences
August 17, 2017Roivant, which had one of the biggest initial public offerings in the history of the biotech industry, is a company that focuses on developing and commercializing novel therapies through subsidiary “Vants.”
Pharma Sources Insight January 2025
